beta-lactams has been researched along with Candida Infection in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Cui, W; Dong, Z; Gao, Y; Li, H; Liu, F; Tang, K; Wang, L; Zhang, G; Zhang, K; Zheng, C; Zhong, L; Zhou, H | 1 |
| Qiao, Y; Tan, CT; Wang, Y; Xu, X | 1 |
| Aguiar Cordeiro, R; Carneiro Câmara, LM; Colares de Andrade, AR; Costa Sidrim, JJ; de Alencar, LP; de Jesus Evangelista, AJ; de Oliveira, JS; Gadelha Rocha, MF; Leite Mendes, PB; Nogueira Brilhante, RS; Sales, JA; Serpa, R; Silva Franco, JD; Souza Collares Maia Castelo-Branco, D | 1 |
| Biswal, J; Dhamodharan, P; Gowri, M; Jeyakanthan, J; Kandaswamy, D; Pitani, R; Raghunathan, R; Rayala, SK; Rohan prasad, S; Saiharish, R; Sofi Beaula, W; Venkatraman, G | 1 |
4 other study(ies) available for beta-lactams and Candida Infection
| Article | Year |
|---|---|
Incidence, clinical characteristics, risk factors and outcomes of patients with mixed Candida/bacterial bloodstream infections: a retrospective study.
Topics: Adult; Bacteria; Bacterial Infections; beta-Lactams; Candida; Candida albicans; Candidemia; Candidiasis; Coinfection; Humans; Incidence; Klebsiella pneumoniae; Retrospective Studies; Risk Factors | 2022 |
A peptidoglycan storm caused by β-lactam antibiotic's action on host microbiota drives Candida albicans infection.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Candida albicans; Candidiasis; Cell Wall; Chromatography, Liquid; Female; Gastrointestinal Microbiome; Gram-Negative Bacteria; Humans; Hyphae; Mass Spectrometry; Mice; Mice, Inbred BALB C; Peptidoglycan; Staphylococcal Infections; Staphylococcus aureus | 2021 |
β-lactam antibiotics & vancomycin increase the growth & virulence of Candida spp.
Topics: Animals; Antifungal Agents; beta-Lactams; Caenorhabditis elegans; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Vancomycin; Virulence | 2018 |
β-lactam substituted polycyclic fused pyrrolidine/pyrrolizidine derivatives eradicate C. albicans in an ex vivo human dentinal tubule model by inhibiting sterol 14-α demethylase and cAMP pathway.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; beta-Lactams; Candida albicans; Candidiasis; Cyclic AMP; Dental Pulp Cavity; Humans; Models, Biological; Second Messenger Systems; Sterol 14-Demethylase | 2016 |